Not all brains are the same. This panel will explore how experts evaluate blood biomarker accuracy in diverse real-world populations, including individuals of different races and ethnicities, and those with comorbidities that may affect readings or symptom severity. We will discuss how doctors communicate these results and assess whether we are ready to implement these diagnostics across all populations. Key Question: Are we ready to implement diagnostics across all populations?
